Beacon Group

Welcome to BEACON Group! Founded in 2006, BEACON Group is one of the fastest-growing conglomerates in Bangladesh, with a strong commitment to improving global healthcare. Our journey began with BEACON Pharmaceuticals, driven by a vision to become a global leader in the pharmaceutical industry. From day one, BEACON has been dedicated to manufacturing and marketing innovative, life-saving medicines that address some of the world’s most critical health challenges, including cancer, hepatitis, and other life-threatening diseases. Today, BEACON is proud to be: ✅ The No. 1 oncology company in Bangladesh ✅ One of the country’s leading pharmaceutical companies Our Companies: BEACON Pharmaceuticals Ltd. BEACON Cephalosporin Ltd. BEACON Developments Ltd. BEACON Medicare Ltd. BEACON Point Ltd. BEACON Pharmaceuticals manufactures over 350 products, including: 🔹 97 oncology medicines 🔹 29 treatments for kidney and liver diseases We operate five state-of-the-art manufacturing facilities, designed and engineered by renowned European consultants. These facilities meet rigorous international standards, including: ✔️ US FDA ✔️ UK MHRA ✔️ TGA Australia ✔️ Local regulatory compliance After meeting domestic demand, BEACON exports high-quality medicines worldwide. Through our Global Patient Support Program, patients across 134 countries—including the USA, Europe, and Australia—have access to BEACON’s affordable and innovative treatments. At BEACON Group, we remain committed to transforming lives and contributing to global healthcare.